{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:20:57Z","timestamp":1779088857836,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.yebeh.2014.10.021","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T12:45:12Z","timestamp":1418474712000},"page":"129-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Cosmetic side effects of antiepileptic drugs in adults with epilepsy"],"prefix":"10.1016","volume":"42","author":[{"given":"B.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.J.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Legge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Buchsbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Detyniecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yebeh.2014.10.021_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.seizure.2008.11.006","article-title":"The impact of side effects on long-term retention in three new antiepileptic drugs","volume":"18","author":"Bootsma","year":"2009","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.yebeh.2014.10.021_bb0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.seizure.2007.01.004","article-title":"Comparative retention rates and long-term tolerability of new antiepileptic drugs","volume":"16","author":"Chung","year":"2007","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.seizure.2013.11.009","article-title":"Side-effects of antiepileptic drugs: the economic burden","volume":"23","author":"de Kinderen","year":"2013","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.yebeh.2014.10.021_bb0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1358\/dot.2005.41.8.893630","article-title":"Drug-induced weight gain","volume":"41","author":"Ness-Abramof","year":"2005","journal-title":"Drugs Today (Barc)"},{"issue":"2","key":"10.1016\/j.yebeh.2014.10.021_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.73.2.121","article-title":"Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management","volume":"73","author":"Bauer","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6406","key":"10.1016\/j.yebeh.2014.10.021_bb0030","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1136\/bmj.287.6406.1669","article-title":"Acne and anticonvulsants","volume":"287","author":"Greenwood","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"8","key":"10.1016\/j.yebeh.2014.10.021_bb0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11536190-000000000-00000","article-title":"Alopecia in association with lamotrigine use: an analysis of individual case safety reports in a global database","volume":"33","author":"Tengstrand","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.yebeh.2014.10.021_bb0040","first-page":"b140","article-title":"The effects of antiepileptic drugs on oral health","volume":"77","author":"Cornacchio","year":"2011","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.yebeh.2014.10.021_bb0045","series-title":"Effectiveness and safety of antiepileptic medications in patients with epilepsy","author":"Talati","year":"2011"},{"issue":"8 Pt 2","key":"10.1016\/j.yebeh.2014.10.021_bb0050","doi-asserted-by":"crossref","first-page":"159S","DOI":"10.1592\/phco.20.12.159S.35249","article-title":"Special considerations for women with epilepsy","volume":"20","author":"Yerby","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.yebeh.2014.10.021_bb0055","series-title":"ATC\/DDD classification (final)","year":"2011"},{"issue":"5","key":"10.1016\/j.yebeh.2014.10.021_bb0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","article-title":"Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy","volume":"51","author":"Canevini","year":"2010","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0317167100021879","article-title":"Weight gain in epileptic patients during treatment with valproic acid: a retrospective study","volume":"24","author":"Corman","year":"1997","journal-title":"Can J Neurol Sci"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2014.10.021_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2013.08.016","article-title":"Metabolic and endocrine effects of valproic acid chronic treatment","volume":"107","author":"Belcastro","year":"2013","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.yebeh.2014.10.021_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0253-7613.108315","article-title":"Serum drug level-related sodium valproate-induced hair loss","volume":"45","author":"Ramakrishnappa","year":"2013","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"10.1016\/j.yebeh.2014.10.021_bb0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0404.1984.tb00804.x","article-title":"Weight gain during treatment with valproate","volume":"70","author":"Dinesen","year":"1984","journal-title":"Acta Neurol Scand"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2014.10.021_bb0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0920-1211(03)00085-8","article-title":"Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res"},{"issue":"13","key":"10.1016\/j.yebeh.2014.10.021_bb0090","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/00002018-200124130-00004","article-title":"Bodyweight gain and anticonvulsants: a comparative review","volume":"24","author":"Jallon","year":"2001","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.seizure.2006.12.009","article-title":"Valproate, weight gain and carbohydrate craving: a gender study","volume":"16","author":"El-Khatib","year":"2007","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.yebeh.2014.10.021_bb0100","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1528-1157.2001.0420081002.x","article-title":"Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy","volume":"42","author":"Stephen","year":"2001","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.yebeh.2006.02.008","article-title":"Insulin-related metabolic changes during treatment with valproate in patients with epilepsy","volume":"8","author":"Pylv\u00e4nen","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00023210-200519030-00003","article-title":"Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy","volume":"19","author":"Isojarvi","year":"2005","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000197868","article-title":"Valproate-induced insulin resistance and obesity in children","volume":"71","author":"Verrotti","year":"2009","journal-title":"Horm Res"},{"issue":"10","key":"10.1016\/j.yebeh.2014.10.021_bb0120","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1053\/meta.2002.34708","article-title":"Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy","volume":"51","author":"Luef","year":"2002","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.yebeh.2014.10.021_bb0125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/0269881108091595","article-title":"Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial","volume":"23","author":"Martin","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"5919","key":"10.1016\/j.yebeh.2014.10.021_bb0130","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.2.5919.584","article-title":"Sodium valproate in treatment of epilepsy","volume":"2","author":"Jeavons","year":"1974","journal-title":"Br Med J"},{"issue":"11","key":"10.1016\/j.yebeh.2014.10.021_bb0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199209103271104","article-title":"A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic\u2013clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group","volume":"327","author":"Mattson","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.yebeh.2014.10.021_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10401230009147085","article-title":"Hair loss in psychopharmacology","volume":"12","author":"Mercke","year":"2000","journal-title":"Ann Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/10401239609147756","article-title":"Alopecia and mood stabilizer therapy","volume":"8","author":"McKinney","year":"1996","journal-title":"Ann Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.yebeh.2014.10.021_bb0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejpn.2008.08.007","article-title":"The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity","volume":"13","author":"Yilmaz","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"issue":"1\u20133","key":"10.1016\/j.yebeh.2014.10.021_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/BTER:102:1-3:001","article-title":"Effect of long-term therapy with sodium valproate on nail and serum trace element status in epileptic children","volume":"102","author":"Armutcu","year":"2004","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"10.1016\/j.yebeh.2014.10.021_bb0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-973560","article-title":"Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy","volume":"29","author":"Graf","year":"1998","journal-title":"Neuropediatrics"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2014.10.021_bb0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02910672","article-title":"Serum and hair zinc levels in epileptic children taking valproic acid","volume":"58","author":"Altunba\u015fak","year":"1997","journal-title":"Biol Trace Elem Res"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2014.10.021_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0920-1211(01)00322-9","article-title":"Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1year of sodium valproate and carbamazepine therapy","volume":"48","author":"Verrotti","year":"2002","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0175","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1528-1157.1992.tb01709.x","article-title":"Serum copper and zinc levels in epileptic children with valproate treatment","volume":"33","author":"Kaji","year":"1992","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0180","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s12011-011-9003-3","article-title":"Valproic acid modulates superoxide dismutase, uric acid-independent FRAP and zinc in blood of adult epileptic patients","volume":"143","author":"P\u0142onka-P\u00f3\u0142torak","year":"2011","journal-title":"Biol Trace Elem Res"},{"issue":"10","key":"10.1016\/j.yebeh.2014.10.021_bb0185","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1528-1157.2001.47000.x","article-title":"Low serum biotinidase activity in children with valproic acid monotherapy","volume":"42","author":"Schulpis","year":"2001","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.yebeh.2014.10.021_bb0190","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1177\/0883073811409227","article-title":"The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity","volume":"26","author":"Castro-Gago","year":"2011","journal-title":"J Child Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2014.10.021_bb0195","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0030-4220(72)90228-9","article-title":"Incidence of diphenylhydantoin gingival hyperplasia","volume":"34","author":"Angelopoulos","year":"1972","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"4","key":"10.1016\/j.yebeh.2014.10.021_bb0200","first-page":"215","article-title":"Drug-induced gingival overgrowth","volume":"12","author":"Seymour","year":"1993","journal-title":"Adverse Drug React Toxicol Rev"},{"issue":"2","key":"10.1016\/j.yebeh.2014.10.021_bb0205","first-page":"73","article-title":"Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation","volume":"20","author":"Prasad","year":"2002","journal-title":"J Indian Soc Pedod Prev Dent"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1752-7325.1973.tb00658.x","article-title":"Gingival hyperplasia during Dilantin-therapy; a survey of 312 patients","volume":"33","author":"Klar","year":"1973","journal-title":"J Public Health Dent"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00002018-199615030-00007","article-title":"Gingival enlargement induced by drugs","volume":"15","author":"Brunet","year":"1996","journal-title":"Drug Saf"},{"issue":"3B","key":"10.1016\/j.yebeh.2014.10.021_bb0220","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1590\/S0004-282X1999000500008","article-title":"Phenytoin as the first option in female epileptic patients?","volume":"57","author":"Trevisol-Bittencourt","year":"1999","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"10.1016\/j.yebeh.2014.10.021_bb0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-051x.2000.027004217.x","article-title":"Risk factors for drug-induced gingival overgrowth","volume":"27","author":"Seymour","year":"2000","journal-title":"J Clin Periodontol"},{"issue":"10","key":"10.1016\/j.yebeh.2014.10.021_bb0230","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1902\/jop.2004.75.10.1424","article-title":"Drug-associated gingival enlargement","volume":"75","author":"Dongari-Bagtzoglou","year":"2004","journal-title":"J Periodontol"},{"key":"10.1016\/j.yebeh.2014.10.021_bb0235","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/2152-7806.119232","article-title":"A study on gingival enlargement and folic acid levels in phenytoin-treated epileptic patients: testing hypotheses","volume":"4","author":"Singh Nayyar","year":"2013","journal-title":"Surg Neurol Int"},{"issue":"2","key":"10.1016\/j.yebeh.2014.10.021_bb0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.seizure.2005.11.002","article-title":"Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6","volume":"15","author":"Sener","year":"2006","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0245","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2710.2008.01000.x","article-title":"Poor oral hygiene enhances gingival overgrowth caused by calcineurin inhibitors","volume":"34","author":"Reali","year":"2009","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.yebeh.2014.10.021_bb0250","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1902\/jop.1999.70.4.445","article-title":"Pronounced palatal and mandibular tori observed in a patient with chronic phenytoin therapy: a case report","volume":"70","author":"Sasaki","year":"1999","journal-title":"J Periodontol"},{"issue":"6","key":"10.1016\/j.yebeh.2014.10.021_bb0255","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S8756-3282(99)00222-7","article-title":"Stimulatory effects of phenytoin on osteoblastic differentiation of fetal rat calvaria cells in culture","volume":"25","author":"Ikedo","year":"1999","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.yebeh.2014.10.021_bb0260","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","article-title":"Dose\u2013response trial of pregabalin adjunctive therapy in patients with partial seizures","volume":"60","author":"French","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2014.10.021_bb0265","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","article-title":"Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose\u2013response study in adults with partial seizures","volume":"45","author":"Arroyo","year":"2004","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0270","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/01.WNL.0000150932.48688.BE","article-title":"Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy","volume":"64","author":"Beydoun","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.yebeh.2014.10.021_bb0275","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1528-1167.2005.00341.x","article-title":"Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study","volume":"46","author":"Elger","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2014.10.021_bb0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0975-5950.102175","article-title":"Pregabalin in post traumatic neuropathic pain: case studies","volume":"3","author":"Singh","year":"2012","journal-title":"Natl J Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.yebeh.2014.10.021_bb0285","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.yebeh.2014.10.021_bb0290","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/157015909788848857","article-title":"Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care","volume":"7","author":"St. Louis","year":"2009","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"10.1016\/j.yebeh.2014.10.021_bb0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0895-4356(91)90265-B","article-title":"Regional obesity and risk of cardiovascular disease; the Framingham Study","volume":"44","author":"Kannel","year":"1991","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.yebeh.2014.10.021_bb0300","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/ajcn\/32.6.1238","article-title":"Obesity, lipids, and glucose intolerance. The Framingham Study","volume":"32","author":"Kannel","year":"1979","journal-title":"Am J Clin Nutr"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014005769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014005769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T08:33:00Z","timestamp":1566117180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505014005769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":60,"alternative-id":["S1525505014005769"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.10.021","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cosmetic side effects of antiepileptic drugs in adults with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}